Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors
Globe Newswire•10/08/2026•16:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.